Calaspargase pegol (Shire)

N/A

Report date: 2026/03/31 20:00:21

Base Information

Drug NameCalaspargase pegol (Shire)
Drug Alias NameSC-PEG asparaginaseScalasparagase pegolOncaspar-IVSC-PEG E. coli L-asparaginaseCal-PEG +[10] 
ClassificationBiologics > Protein drugs > Enzyme > Non-recombinant enzyme
Mechanisms of ActionAspartate-ammonia ligase inhibitorsAmidohydrolases stimulantsAsparagine inhibitors
TargetsAspartate-ammonia ligaseAmidohydrolasesAsparagine
Therapy Area/IndicationsPrecursor T-Cell Lymphoblastic Leukemia-LymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, B-Cell
Global Approved IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2018/12/20
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesShire
China Registration ClassN/A

Develop Information

Active CompaniesDana-Farber Cancer InstituteShireServier Pharmaceuticals Llc
Inactive CompaniesInstitut De Recherches Internationales ServierNational Cancer Institute
Active IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsPrecursor T-Cell Lymphoblastic Leukemia-LymphomaLeukemia, B-Cell

Other Information

ATC CodeL01XX02
Related LinksN/A